On Capitol Hill, China Themes Increasingly Center On Trade Theft, Espionage, IP Violations
How did China become a near peer competitor with the U.S. on everything from computers to AI platforms to space? Theft and IP violations.
In Hearing, Congress Says China Stealing American AI Models, But Witnesses Focus On More Obvious Problems
Leadership of the House Select Committee on the CCP is convinced China is stealing American AI models. That’s why China has an OpenAI rival, called DeepSeek, and the Europeans have nothing.
War, AI, and Grid Stress: Why This Is Solar Power’s Moment
The war in Iran is solar power’s Covid moment.
Warnings Of China Taking Lead In Biopharma Future In Latest Senate Hearing
China holds a rapidly expanding position in the global biologics and biosimilars market, driven by heavy government support, regulatory reforms, and massive investments in biotech hubs like Shanghai and Suzhou.
Are Tariffs a Burden? CPA Senior Economist Mihir Torsekar Debates The Tax Foundation at Ohio State University
If there is one Washington, D.C.-based organization that is outspoken against the positions of CPA, it’s the Tax Foundation. They have been instrumental in getting many legislators to believe tariffs would be a “tax” upwards of $1,000 per household.
House Committee Discusses Project Vault And Need To Onshore The Critical Minerals Supply Chain
Project Vault was developed to lend money to miners and entice investment in metals processing in order to build a strategic reserve of critical minerals to protect industry from supply shocks and price volatility.
For China Commission, Warnings and Advice For Trump’s “Donroe Doctrine” in Latin America
Last November, the White House released its National Security Strategy of the United States that laid out the Trump administration’s strategy for the Americas. In it, the strategy imperative for the region said that one of Washington’s key goals was to make sure the Americas remains “free of hostile foreign incursion or ownership of key assets,” and was supportive of U.S. access to critical supply chains. China wasn’t mentioned by name as the hostile adversary, but China is precisely who the White House had in mind.
In House Hearing, Unanimous Agreement on China Risks in American Rx Supply
Everyone agrees, in particular that reliance on China for key ingredients used to make medicines is risky; and everyone agrees that further up market – in advanced biotech – China is becoming an unmatched rival that could easily shrink America’s role in drug innovation.
Should Chinese Nationals Be Allowed to Donate to American Colleges, Participate in Research Grants?
Should Chinese organizations and individuals be allowed to donate to American colleges, and should their PhD students have access to scientific research grants? It’s not an easy question to answer.
Sen. Gillibrand Says U.S. Generics Need Incentives to Reshore; Cost Shouldn’t Trump Quality
It’s the second month in a row now that the U.S. Senate Special Committee on Aging has taken up the question of our woeful generics supply chain. This time, however, Ranking Member Kirsten Gillibrand (D-NY), started the hearing off by touching on a key topic in pharmaceuticals: the cost equation can no longer override the quality equation.
